Bicycle Therapeutics (BCYC) Total Current Liabilities: 2018-2025

Historic Total Current Liabilities for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to $69.3 million.

  • Bicycle Therapeutics' Total Current Liabilities rose 22.83% to $69.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year increase of 22.83%. This contributed to the annual value of $67.2 million for FY2024, which is 3.32% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Total Current Liabilities stood at $69.3 million for Q3 2025, which was down 10.51% from $77.4 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Total Current Liabilities registered a high of $77.4 million during Q2 2025, and its lowest value of $20.8 million during Q1 2021.
  • Over the past 3 years, Bicycle Therapeutics' median Total Current Liabilities value was $69.3 million (recorded in 2025), while the average stood at $64.7 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Total Current Liabilities skyrocketed by 77.64% in 2022 and then declined by 19.12% in 2024.
  • Bicycle Therapeutics' Total Current Liabilities (Quarterly) stood at $36.2 million in 2021, then soared by 47.20% to $53.3 million in 2022, then skyrocketed by 30.36% to $69.5 million in 2023, then fell by 3.32% to $67.2 million in 2024, then rose by 22.83% to $69.3 million in 2025.
  • Its Total Current Liabilities was $69.3 million in Q3 2025, compared to $77.4 million in Q2 2025 and $57.6 million in Q1 2025.